Back to Resource Center

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Estimating the market size for a dual prevention pill: adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake

Research findings suggest that the dual prevention pill (DPP), an oral contraceptive combined with pre-exposure prophylaxis (PrEP) to prevent HIV in women, may lead to a 2- to 10-fold increase in PrEP use in 15 sub-Saharan countries — a potential market of more than 1 million users. DPP consists of a 28-day dual prevention pill regimen in development by Population Council and currently in Phase 4 Post-marketing Trials.

View Journal Article

July 2020

Click for full info +

Full Info:


Resource Type:

Journal Article

Citation:

Research findings suggest that the dual prevention pill (DPP), an oral contraceptive combined with PrEP to prevent HIV, may lead to a 2- to 10-fold increase in PrEP use in 15 sub-Saharan countries — a potential market of more than 1 million users

Authors:

Begg L., Brodsky R., Friedland B.Mathur, S., Sailer J., & Creasy G.

Health Risks(s):

  • HIV
  • Unintended Pregnancy

Product type(s):

  • Contraceptives
  • Hormonal
  • MPTs

Topic(s):

  • MPTs
  • Development
  • Product Introduction
  • Trials

    Region(s)

    • Africa
    • Global

    Back to Resource Center